Clovis Oncology to Present at the 2016 Credit Suisse Healthcare Conference

Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick Mahaffy, the Company’s President and CEO, will present at the 2016 Credit Suisse Healthcare Conference on Tuesday, November 8, at 1:00pm MST. The conference is being held at the Phoenician in Scottsdale, Arizona.

A live webcast of the corporate presentation at the conference will be accessible through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161031005013/en/